Discovery of Vulnerability in Glioblastoma at Ohio Institution

Buzzline

Scientists at The Ohio State University have uncovered a possible vulnerability in glioblastoma, a highly lethal and notoriously treatment-resistant form of brain cancer. Their research indicates that inhibiting the protein SET and its associated proteins may reactivate PP2A, an enzyme crucial for the survival and repair of cancer cells. In both laboratory settings and animal studies, the suppression of these proteins hindered tumor formation and heightened the sensitivity of the remaining cancer cells to radiation therapy. These results are preliminary and have yet to be evaluated in human subjects. The team is currently investigating the safety of targeting this pathway to enhance current treatment strategies.  Disclosure: This video contains stock footage and content created or enhanced using Al-assisted tools. ai-generated

Transcript

00:00Scientists in Ohio may have found a weak spot in deadly brain cancer.

00:04Researchers at Ohio State studied aggressive glioblastoma.

00:08The cancer often resists radiation and chemotherapy.

00:12Scientists focused on a protein called SET.

00:14C8 appears to help cancer cells survive treatment.

00:18In lab and animal models, blocking SET stopped tumors from developing.

00:23Researchers also targeted proteins that suppress PP2A.

00:27PP2A helps control cancer cell growth and survival.

00:30Blocking these proteins made cancer cells more sensitive to radiation.

00:35The goal is to make existing treatments work better.

00:37But this research has not yet been tested in patients.

00:41Researchers are now studying whether the approach is safe and effective.

00:45Disclosure.

00:46This video contains stock footage and content created, or enhanced, using AI-assisted tools.

Category

Transcript

Comments

Recommended